ZFP82 and neoplasm: Previous literature has highlighted the downregulation of ZFP82 through promoter methylation in esophageal squamous cell carcinoma, which is associated with age, tumor stage as well as the prognosis of squamous cell carcinoma (Ye et al., 2019).